Kliinisen farmakologian yks.

Julkaisut 2012
Publications 2012

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Blennow K et al. Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease.
2 Diamanti E et al. Might the observed alpha(2A)-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations?
3 Dutia R et al. Regulation of prolactin in mice with altered hypothalamic melanocortin activity.
4 Fallarero A et al. High-throughput screening with a miniaturized radioligand competition assay identifies new modulators of human alpha 2-adrenoceptors.
5 Hagelberg N et al. Striatal µ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.
6 Helin-Salmivaara A et al. Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland.
7 Helin-Salmivaara A et al. Statins and hip fracture prevention - a population based cohort study in women.
8 Holopainen IE, Laurén B. Glutamate signaling in the pathophysiology and therapy of prenatal insults.
9 Honkavaara J et al. Influence of MK-467, a peripherally acting alpha2-adrenoceptor antagonist on the disposition of intravenous dexmedetomidine in dogs.
10 Iirola T. Observations on the pharmacokinetics and pharmacodynamics of dexmedetomidine.
11 Iirola T et al. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients.
12 Kohli U et al. CYP2A6 genetic variation and dexmedetomidine disposition.
13 Koivunen J et al. Cognitive decline and amyloid accumulation in patients with mild cognitive impairment.
14 Koskinen J et al. Association of liver enzymes with metabolic syndrome and carotid atherosclerosis in young adults. The Cardiovascular Risk in Young Finns Study. .
15 Kukko-Lukjanov TK et al. Histamine 1 receptor knock out mice show age-dependent susceptibility to status epilepticus and consequent neuronal damage.
16 Mansikkaniemi K et al. Cross-sectional associations between physical activity and selected coronary heart disease risk factors in young adults. The Cardiovascular Risk in Young Finns Study.
17 Matic I et al. Bone-specific overexpression of NPY modulates osteogenesis.
18 Oikonen M et al. Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study.
19 Peltoniemi MA et al. Rifampicin has a profound effect on the pharmacokinetics of oral S-Ketamine and less on intravenous S-Ketaminen .
20 Peltoniemi MA et al. S-ketamine concentrations are greatly increased by grapefruit juice.
21 Peltoniemi MA et al. St John`s wort greatly decreases the plasma concentrations of oral S-ketamine.
22 Posti J. Alpha2-Adrenoceptor-mediated Vascular Responses Induced by Dexmedetomidine.
23 Raiko JRH et al. Plasminogen activator inhitor-1 associates with cardiovascular risk factors in healthy young adults in the Cardiovascular Risk in Young Finns Study.
24 Rinne JO et al. [18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid ß detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
25 Rinne P et al. Hemodynamic actions and mechanisms of systemically administered alfa-MSH analogs in mice.
26 Ruohonen ST et al. Involvement of alpha2-adrenoceptor subtypes A and C in glucose homeostasis and adrenaline-induced hyperglycaemia.
27 Ruohonen ST et al. Diet-induced obesity in mice overexpressing neuropeptide y in noradrenergic neurons.
28 Saczewski J et al. Synthesis and biological activities of 2-[(heteroaryl)methyl]imidazolines.
29 Snellman A et al. Pharmacokinetics of [¹8F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.
30 Sulosaari V et al. Nurse students' medication competence - An integrative review of the associated factors.
31 Toriseva M et al. MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability.

Julkaisutietokanta 3.9.2013 Publications Data Base 3.9.2013